Novartis AG (NVS)
Novartis AG Return on Equity (ROE)
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 18.3% | 18.9% | 14.4% | 16.4% | 15.7% | 15.7% | 13.6% | 14.2% | 12.9% | 14.8% | 9.5% | 8.8% | 10.3% | 16.5% | 10.6% | 14.4% | 38.6% | 10.9% | 16.1% | 26.3% |
Novartis AG (NVS) Return on Equity (ROE) comparison analysis
NVS key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
FAQ
1) What is Novartis AG's Return on Equity (ROE)?
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 27.3%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Equity (ROE) for Novartis AG have been 24.0% over the past three years, and 22.2% over the past five years.
2) Is Novartis AG's Return on Equity (ROE) Good?
As of today, Novartis AG's Return on Equity (ROE) is 27.3%, which is higher than industry median of 19.9%. It indicates that Novartis AG's Return on Equity (ROE) is Good.